Clinical Trial

SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)

Study acronym: SALVAGE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.
Trial Details
NCT Number NCT07712666
Lead Sponsor Mayo Clinic
Conditions Adult Spinal Deformity Surgery
Enrollment 146 participants
Start Date 2026-08-01
Primary Completion 2028-08-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-17